Cision PR Newswire

Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight...

- Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and Canada.  -...

Euro Tech Holdings Company Limited Reports Contracts Awarded to PACT

HONG KONG, Feb. 25, 2025 /PRNewswire/ -- Euro Tech Holdings Company Limited (Nasdaq: CLWT) today announced that its majority-owned subsidiary, Yixing PACT Environmental Technology Company Ltd....

SUNHOME to Debut Smart Residential Energy System for Global Markets in Thailand

BANGKOK, Feb. 25, 2025 /PRNewswire/ -- SUNHOME, a technology brand in smart residential energy sector, is set to unveil its latest innovations at a global...